Genmab A/S Files 6-K with Interim Report
Ticker: GNMSF · Form: 6-K · Filed: May 8, 2025 · CIK: 1434265
| Field | Detail |
|---|---|
| Company | Genmab A/S (GNMSF) |
| Form Type | 6-K |
| Filed Date | May 8, 2025 |
| Risk Level | low |
| Sentiment | neutral |
Sentiment: neutral
Topics: financial-reporting, interim-report, sec-filing
Related Tickers: GMAB
TL;DR
Genmab filed its interim report on 5/8/25, check the S-8 filings for details.
AI Summary
Genmab A/S filed a Form 6-K on May 8, 2025, to report its interim financial information as of that date. This filing is incorporated by reference into several of Genmab's S-8 registration statements, including File Nos. 333-232693, 333-253519, 333-262970, 333-277273, and 333-284876.
Why It Matters
This filing provides updated financial information for Genmab A/S, which is crucial for investors to assess the company's performance and financial health.
Risk Assessment
Risk Level: low — This is a routine financial reporting filing (6-K) and does not contain new material events or significant financial changes.
Key Players & Entities
- Genmab A/S (company) — Registrant
- May 8, 2025 (date) — Filing Date
- 333-232693 (registration_statement) — Incorporated by reference
- 333-253519 (registration_statement) — Incorporated by reference
- 333-262970 (registration_statement) — Incorporated by reference
- 333-277273 (registration_statement) — Incorporated by reference
- 333-284876 (registration_statement) — Incorporated by reference
FAQ
What type of report is Genmab A/S filing on May 8, 2025?
Genmab A/S is filing a Form 6-K, which is a Report of Foreign Private Issuer.
What is the purpose of this Form 6-K filing?
The purpose is to provide an Interim Report dated May 8, 2025, and to be incorporated by reference into Genmab's existing registration statements.
Which registration statements does this 6-K filing get incorporated into?
This filing is incorporated into Genmab A/S's registration statements on Form S-8 with File Numbers 333-232693, 333-253519, 333-262970, 333-277273, and 333-284876.
What is the principal executive office address for Genmab A/S?
The principal executive offices are located at Carl Jacobsens Vej 30, 2500 Valby, Denmark.
What is the SIC code for Genmab A/S?
The Standard Industrial Classification (SIC) code for Genmab A/S is 2834, which corresponds to Pharmaceutical Preparations.
Filing Details
This Form 6-K (Form 6-K) was filed with the SEC on May 8, 2025 regarding GENMAB A/S (GNMSF).